NYMX
Nymox Pharmaceutical Corp
NYMX
NYMX
Delisted
NYMX was delisted on the 6th of July, 2023.
63 hedge funds and large institutions have $19.9M invested in Nymox Pharmaceutical Corp in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
Holders
63
Holding in Top 10
–
Calls
$621K
Puts
$68K
Top Buyers
| 1 | +$6.2M | |
| 2 | +$1.5M | |
| 3 | +$1.45M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$863K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$570K |
Top Sellers
| 1 | -$1.12M | |
| 2 | -$909K | |
| 3 | -$485K | |
| 4 |
Renaissance Technologies
New York
|
-$161K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$156K |